SCHEMBL9909079

SCHEMBL9909079

CC1(N)CCCCCCCCC1

nearest known ligand 0.38

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
TSHR P16473 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL853285 1.00 ALDH1A1 (0.38) ALDH1A1TDP1TSHRCYP2C19
SCHEMBL284364 1.00
SCHEMBL8919 1.00
SCHEMBL8424624 1.00 ALDH1A1 (0.38) ALDH1A1TDP1TSHRCYP2C19
SCHEMBL22448471 1.00 ALDH1A1 (0.38) ALDH1A1TDP1TSHRCYP2C19
SCHEMBL24054976 1.00 ALDH1A1 (0.38) ALDH1A1TDP1TSHRCYP2C19
SCHEMBL13122851 1.00 ALDH1A1 (0.38) ALDH1A1TDP1TSHRCYP2C19
SCHEMBL10274898 1.00 ALDH1A1 (0.38) ALDH1A1TDP1TSHRCYP2C19
SCHEMBL21120437 1.00 ALDH1A1 (0.38) ALDH1A1TDP1TSHRCYP2C19
SCHEMBL12094717 1.00 ALDH1A1 (0.38) ALDH1A1TDP1TSHRCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230116972-A1 CD38 MODULATORS AND METHODS OF USE THEREOF CYTOKINETICS, INC. 2023-04-20 US disclosed
US-20220380520-A1 STRONG BINDING METAL-CHELATING RESINS USING MACROCYCLE MOLECULES SACHEM, INC. 2022-12-01 US disclosed
WO-2022136844-A1 N-(PYRIDIN-2-YL)-6,7,8,9-TETRAHYDRO-5H-5,8-EPIMINOCYCLOHEPTA[C]PYRIDINE-10-CARBOXAMIDE DERIVATIVES AND SIMILAR COMPOUNDS AS GPR65 MODULATORS FOR THE TREATMENT OF CANCER Pathios Therapeutics Limited (GB) 2022-06-30 WO disclosed
US-20220144839-A1 INDOLE AHR INHIBITORS AND USES THEREOF PAHR THERAPEUTICS, INC. 2022-05-12 US disclosed
WO-2022090724-A1 NOVEL COMPOUNDS SITRYX THERAPEUTICS LIMITED (GB) 2022-05-05 WO disclosed
US-11134676-B2 Anti-microbial particles and methods of use thereof NOBIO LTD. (IL) 2021-10-05 US disclosed
US-20210295005-A1 INTERACTIVE BIOMETRIC TOUCH SCANNER Orchid Sound Technologies LLC 2021-09-23 US disclosed
EP-3326715-B1 OXALIC ACID MONOAMIDE LIGAND, AND USES THEREOF IN COUPLING REACTION OF COPPER-CATALYZED ARYL HALOGEN SUBSTITUTE CE PHARM CO LTD (CN) 2021-09-15 EP disclosed
US-20210163464-A1 PYRIDINE COMPOUND DAIICHI SANKYO COMPANY, LIMITED (JP) 2021-06-03 US disclosed
US-11023704-B2 Interactive biometric touch scanner THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2021-06-01 US disclosed
US-8207286-B2 Methods for preparing polyurethanes PPG INDUSTRIES OHIO, INC (US) 2012-06-26 US disclosed
US-8198298-B2 Pyrrolo[2,3-b]pyridine derivatives active as kinase inhibitors PFIZER ITALIA S.R.L. (IT) 2012-06-12 US disclosed
WO-2012050015-A1 POLYMERIZABLE FLUORINE-CONTAINING SULFONATE, FLUORINE-CONTAINING SULFONATE RESIN, RESIST COMPOSITION AND PATTERN-FORMING METHOD USING SAME セントラル硝子株式会社 (JP) 2012-04-19 WO disclosed
US-20110136857-A1 PYRROLE[2,3-B]PYRIDINE DERIVATIVES ACTIVE AS KINASE INHIBITORS PFIZER ITALIA S.R.L. (IT) 2011-06-09 US disclosed
US-7879955-B2 Compositions including a polythioether PRC-DESOTO INTERNATIONAL, INC. 2011-02-01 US disclosed
US-20100048852-A1 High impact poly(urethane urea) polysulfides PPG INDUSTRIES OHIO, INC. (US) 2010-02-25 US disclosed
US-20090281268-A1 METHODS FOR PREPARING POLYURETHANES PPG INDUSTRIES OHIO, INC. (US) 2009-11-12 US disclosed
CN-101448866-A Natural oil based polyols with intrinsic surpactancy for polyurethane foaming DOW GLOBAL TECHNOLOGIES INC (US) 2009-06-03 CN disclosed
US-20090012244-A1 COMPOSITIONS INCLUDING A POLYTHIOETHER PRC-DESOTO INTERNATIONAL, INC. (US) 2009-01-08 US disclosed
US-20080245263-A1 Phase change inks containing colorant compounds XEROX CORPORATION 2008-10-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220144839-A1 INDOLE AHR INHIBITORS AND USES THEREOF AHR, ARNT, IDO1 ALDH1A1 316/4885TDP1 2915/4885TSHR 974/4885
US-20210163464-A1 PYRIDINE COMPOUND RET, ABL1, ROS1 ALDH1A1 1589/4885TDP1 1797/4885TSHR 1789/4885
US-20230116972-A1 CD38 MODULATORS AND METHODS OF USE THEREOF CD38, CXCR4, FCGRT ALDH1A1 358/4885TDP1 587/4885TSHR 2152/4885
US-20110136857-A1 PYRROLE[2,3-B]PYRIDINE DERIVATIVES ACTIVE AS KINASE INHIBITORS MAP3K6, MAP3K3, MAP3K15 ALDH1A1 4198/4885TDP1 633/4885TSHR 3922/4885
US-11134676-B2 Anti-microbial particles and methods of use thereof LPO, MPO, CAPG ALDH1A1 3866/4885TDP1 3229/4885TSHR 4502/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.